Metformin may curb depression risk in diabetes patients

12/2/2012 | Diabetes.co.uk (U.K.)

Type 2 diabetes patients who were on metformin treatment had a reduced risk of mood disorders such as depression, as well as Parkinson's disease and dementia, especially if sulfonylurea drugs were used as an add-on therapy, a study from Taiwan showed. The results appear in BMC Medicine.

View Full Article in:

Diabetes.co.uk (U.K.)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Sr. Principal OptoMechanical Engineer - 14000008M2
Abbott
San Jose, CA
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Sr. Principal Electrical Engineer - 14000008LR
Abbott
San Jose, CA